Abstract
In medical research, the ethical principle of respect for persons is operationalized into the process of informed consent. The consent tools should be contextualized and adapted to the different socio-cultural environment, especially when research crosses the traditional boundaries and reaches poor communities. We look at the challenges experienced in the malaria Quinact trial, conducted in the Democratic Republic of Congo, and describe some lessons learned, related to the definition of acceptable representative, the role of independent witness and the impact of socio-economic vulnerability. To ensure children's protection, consent is required by the parents or, in their absence, by a legally mandated representative. In our setting, children's responsibility is often entrusted permanently or temporarily to relatives or friends without a tribunal mandate. Hence, a notion of 'culturally acceptable representative' under supervision of the local Ethics Committee may be more suitable. To ensure protection of illiterate subjects, an independent witness is required to confirm that the consent was freely given. However, in low-literacy contexts, potential witnesses often don't have any previous relationship with patient and there may b...Continue Reading
References
Jan 30, 1997·The New England Journal of Medicine·M P PréziosiS G Wassilak
Feb 27, 1999·Social Science & Medicine·A LeachE K Mulholland
Dec 21, 2000·JAMA : the Journal of the American Medical Association
Jan 1, 1994·European Journal of Health Law·Johan Legemaate
Jun 17, 2004·AIDS·UNKNOWN ANRS1201/1202 Ditrame Plus Study Group
Oct 7, 2004·JAMA : the Journal of the American Medical Association·James Flory, Ezekiel Emanuel
Oct 12, 2004·Social Science & Medicine·C S MolyneuxK Marsh
Apr 20, 2005·Journal international de bioéthique = International journal of bioethics·UNKNOWN World Medical Association General Assembly
Jun 4, 2005·American Journal of Public Health·Christine PaceChristine Grady
Dec 25, 2007·Journal of Medical Ethics·Z HillB Kirkwood
Jun 21, 2008·BMC Medical Ethics·Abraham R OduroKwadwo A Koram
Aug 4, 2009·BMC Medical Ethics·Olaniyi O Taiwo, Nancy Kass
Jun 15, 2010·BMC Medical Ethics·Andrew VallelyUNKNOWN Microbicides Development Programme (MDP)
Jul 9, 2010·PLoS Neglected Tropical Diseases·Trudie A LangKevin Marsh
Oct 5, 2010·The American Journal of Tropical Medicine and Hygiene·Ruth D EllisJoseph Millum
Nov 3, 2011·PloS One·Lelia H ChaissonTaraz Samandari
May 23, 2012·PLoS Medicine·Suerie MoonEllen 't Hoen
Jul 24, 2012·BMC Medical Ethics·Mutsa Bwakura-DangarembiziTichaona Vhembo
Sep 27, 2012·BMC Medical Ethics·Rachel VreemanPaula Braitstein
Nov 10, 2012·BMC Medical Ethics·Paul M NdebeleFrancis Masiye
Sep 26, 2013·Trials·Hypolite Muhindo MavokoJean-Pierre Van Geertruyden
Nov 22, 2013·PloS One·Lea Paré ToeKoen Peeters Grietens
Dec 25, 2013·PloS One·Vivi MaketaPascal Lutumba
Mar 19, 2014·Tropical Medicine & International Health : TM & IH·Muhammed O AfolabiDaniel Chandramohan
Oct 11, 2014·Tropical Medicine & International Health : TM & IH·Raffaella M RavinettoKoen Peeters Grietens
Aug 1, 2015·Bulletin of the World Health Organization·Muhammed Olanrewaju AfolabiKalifa Bojang
Citations
Jun 5, 2016·Tropical Medicine & International Health : TM & IH·N VischerC Burri
Jan 5, 2018·Science and Engineering Ethics·Dianne QuigleyXiaofan Wei
Jul 1, 2017·BMC Public Health·Yandisa SikweyiyaRachel Jewkes
Oct 12, 2017·The American Journal of Bioethics : AJOB·Subrata ChattopadhyayRaymond De Vries
Jan 8, 2019·BMJ Paediatrics Open·Marcela Colom, Peter Rohloff
May 25, 2016·The American Journal of Bioethics : AJOB·Wim PinxtenAnne Buvé
May 19, 2017·The New England Journal of Medicine·Muhammed O Afolabi, Alberto L García-Basteiro
May 18, 2017·The New England Journal of Medicine·Christine Grady
Jun 30, 2021·BMJ Global Health·Gwen LemeyJean-Pierre Van Geertruyden